Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant.
Norwegian Firm CardiNor Raises $1.4M to Develop Cardiovascular Disease ELISA Test
The company said it has demonstrated the potential of secretoneurin to support patient selection for implantable cardioverter defibrillators, among other uses.
Prevencio, Atlas Genomics to Commercialize Cardiac Blood Tests
The tests use Microsoft's Azure AI-based computing cloud platform for test algorithm processing and scoring and for report generation and delivery.
Calciscon Raises $2.7M in Series A Round
The Swiss company said it will use the funding to accelerate commercialization of its blood-based calcification propensity test for kidney disease patients.
Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test
The technology underlying the test was developed by Dutch firm Minicare, which was acquired by Siemens in 2019.